TMU Research Center of Cancer Translational Medicine

Organization profile

Organisation profile

The TMU Research Center of Cancer Translational Medicine (RCCTM) is established through combining all cancer-related resources of TMU and its three affiliated hospitals. RCCTM is established with the goal of translating the research discoveries into state-of-the-art therapeutics for the prevention and treatment of cancer, as well as training future oncologists. We are committed to reduce the cancer burden through skilled, integrated and compassionate clinical care, and to eliminate the threat of cancer through research and education.

Fingerprint Dive into the research topics where TMU Research Center of Cancer Translational Medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Neoplasms Medicine & Life Sciences
Taiwan Medicine & Life Sciences
Meta-Analysis Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Cells Chemical Compounds
Neoplasm Metastasis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2020

通過老藥新用來開發新的肝癌治療選擇(2/2)

Whang-Peng, J.

8/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

奈米HEVnp於晚期大腸直腸癌患者的治療策略(1/3)

Whang-Peng, J.

8/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

Research Output 1958 2020

Optimal measuring timing of cystatin C for early detection of contrast-induced acute kidney injury: A systematic review and meta-analysis

Chen, C. T., Chang, L. Y., Chuang, C. W., Wang, S. C., Kao, M. C., Tzeng, I. S., Kuo, K. L., Wu, C. C., Tsai, P. S. & Huang, C. J., Jan 2020, In : Toxicology Letters. 318, p. 65-73 9 p.

Research output: Contribution to journalArticle

Cystatin C
Acute Kidney Injury
Meta-Analysis
Contrast Media
Peripheral Catheterization
4 Citations (Scopus)

1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase

Lai, M. J., Ojha, R., Lin, M. H., Liu, Y. M., Lee, H. Y., Lin, T. E., Hsu, K. C., Chang, C. Y., Chen, M. C., Nepali, K., Chang, J. Y. & Liou, J. P., Jan 15 2019, In : European Journal of Medicinal Chemistry. 162, p. 612-630 19 p.

Research output: Contribution to journalArticle

Benzamides
Histone Deacetylases
Tubulin
Heterografts
Inhibitory Concentration 50
Curcumin
Endothelin-1
Fibroblasts
Thrombin
Phosphotransferases